Literature DB >> 8297719

Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.

K Foster1, P A Crossey, P Cairns, J W Hetherington, F M Richards, M H Jones, E Bentley, N A Affara, M A Ferguson-Smith, E R Maher.   

Abstract

To investigate the role of tumour-suppressor genes on the short arm of chromosome 3 in the mechanism of tumorigenesis in non-familial renal cell carcinoma, we analysed 55 paired blood-tumour DNA samples for allele loss on chromosome 3p and in the region of known or putative tumour-suppressor genes on chromosomes 5, 11, 17 and 22. Sixty-four per cent (35/55) of informative tumours showed loss of heterozygosity (LOH) of at least one locus on the short arm of chromosome 3, compared with only 13% at the p53 tumour-suppressor gene and 6% at 17q21. LOH at chromosome 5q21 and 22q was uncommon (2-3%). Detailed analysis of the regions of LOH on chromosome 3p suggested that, in addition to the VHL gene in chromosome 3p25-p26, mutations in one or more tumour-suppressor genes in chromosome 3p13-p24 may be involved in the pathogenesis of sporadic renal cell carcinoma (RCC). We also confirmed previous suggestions that chromosome 3p allele loss is not a feature of papillary RCC (P < 0.05).

Entities:  

Mesh:

Year:  1994        PMID: 8297719      PMCID: PMC1968700          DOI: 10.1038/bjc.1994.44

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis.

Authors:  E R Maher; E Bentley; J R Yates; F Latif; M Lerman; B Zbar; N A Affara; M A Ferguson-Smith
Journal:  Genomics       Date:  1991-08       Impact factor: 5.736

2.  The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB.

Authors:  A H van der Hout; P van der Vlies; C Wijmenga; F P Li; J W Oosterhuis; C H Buys
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

3.  Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.

Authors:  P Anglard; K Tory; H Brauch; G H Weiss; F Latif; M J Merino; M I Lerman; B Zbar; W M Linehan
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

4.  Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Authors:  B R Seizinger; D I Smith; M R Filling-Katz; H Neumann; J S Green; P L Choyke; K M Anderson; R N Freiman; S M Klauck; J Whaley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.

Authors:  K Yamakawa; R Morita; E Takahashi; T Hori; J Ishikawa; Y Nakamura
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

6.  Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3.

Authors:  S Hosoe; H Brauch; F Latif; G Glenn; L Daniel; S Bale; P Choyke; M Gorin; E Oldfield; A Berman
Journal:  Genomics       Date:  1990-12       Impact factor: 5.736

7.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

8.  Isolation and mapping of 68 RFLP markers on human chromosome 6.

Authors:  S Saito; K Okui; T Tokino; M Oshimura; Y Nakamura
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

9.  Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p.

Authors:  M H Jones; K Yamakawa; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

10.  Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis.

Authors:  Y Suzuki; G Tamura; R Satodate; T Fujioka
Journal:  Jpn J Cancer Res       Date:  1992-03
View more
  25 in total

1.  Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma.

Authors:  Ponniah Selvakumar; Tori A Owens; Justin M David; Nicholas J Petrelli; Brock C Christensen; Ashakumary Lakshmikuttyamma; Ayyappan K Rajasekaran
Journal:  Epigenetics       Date:  2014-01-22       Impact factor: 4.528

2.  Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization.

Authors:  A Szeles; S Bajalica-Lagercrantz; A Lindblom; T Lushnikova; V I Kashuba; S Imreh; M Nordenskjöld; G Klein; E R Zabarovsky
Journal:  Chromosome Res       Date:  1996-06       Impact factor: 5.239

3.  DNA Methylation and Flavonoids in Genitourinary Cancers.

Authors:  Neelam Mukherjee; Addanki P Kumar; Rita Ghosh
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

4.  Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.

Authors:  Y Yang; M Kost-Alimova; S Ingvarsson; Q Qianhui; H Kiss; A Szeles; I Kholodnyuk; A Cuthbert; G Klein; S Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.

Authors:  Francesca Lessi; Chiara Maria Mazzanti; Sara Tomei; Claudio Di Cristofano; Andrea Minervini; Michele Menicagli; Alessandro Apollo; Lorenzo Masieri; Paola Collecchi; Riccardo Minervini; Marco Carini; Generoso Bevilacqua
Journal:  Med Oncol       Date:  2014-01-21       Impact factor: 3.064

6.  Immune and genetic therapies for advanced renal cell carcinoma.

Authors:  A Zisman; A J Pantuck; A Belldegrun
Journal:  Rev Urol       Date:  2000

7.  Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.

Authors:  H J Decker; C Neuhaus; A Jauch; M Speicher; T Ried; M Bujard; H Brauch; S Störkel; M Stöckle; B Seliger; C Huber
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

8.  Loss of heterozygosity and methylation of p16 in renal cell carcinoma.

Authors:  M T Sanz-Casla; M L Maestro; V del Barco; I Zanna; J Moreno; M Vidaurreta; I Almansa; C Fernández; J Blanco; C Maestro; L Resel
Journal:  Urol Res       Date:  2003-03-25

9.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

10.  Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.

Authors:  N J Froggatt; J Koch; R Davies; D G Evans; A Clamp; O W Quarrell; J Weissenbach; S V Hodgson; B A Ponder; D E Barton
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.